Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Dr. Rentschler Holding and Rentschler Biopharma choose prevero's BI solution

Rentschler Biopharma
Posted on: 04 Dec 17

Prevero, a unit4 company and software provider for Business Intelligence and Corporate Performance Management solutions, has been selected by the global biopharmaceutical manufacturer Rentschler Biopharma, and its parent Dr. Rentschler Holding, to improve business insights across the company’s subsidiaries

Rentschler was looking for a Business Intelligence (BI) tool to facilitate faster business decisions, detailed planning, and more meaningful reporting while enabling the simulation of different business scenarios. The company's legacy system had reached the limit of what it could deliver in terms of integrated planning, visualisation and simulation.

Prevero was selected from a short-list of vendors for its future-oriented development approach and the ability to integrate a separate module for HR management. Another decisive aspect was its ability to meet the requirements of both Dr. Rentschler Holding and its subsidiaries.

Dr. Rentschler Holding started its selection process with extensive market research and chose prevero based on its impressive proof of concept. Originally intended solely for Dr. Rentschler Holding, implementation of the solution has now expanded to include Rentschler Biopharma.

Robert Schmid, project leader at Rentschler Holding said: "We realised very quickly that the solution could deliver a broad variety of requirements, and that we could achieve more with it than originally planned.

"Our goal was to optimise the quality and reliability of data across all subsidiaries. When the project is complete, we will have more time to analyse business information instead of just generating it."

Thomas Lottner, Vice President Finance at Rentschler Biopharma, said: "prevero's solution enables us to monitor all the development and production steps of our complex service business.

"With a rolling 48-month forecast against specific KPIs, we are better able to manage in a future-oriented way. Moreover, the system helps us establish a single point of truth. The development and production divisions can focus on core activities and continue to ensure superior quality for our clients."

Matthias Thurner, CTO and co-founder of prevero, added: "We are very happy that our solution and approach convinced Rentschler to select us. We will do everything we can to provide them with optimal support through every step of the rollout."

Rentschler Holding is planning to launch the solution including all functions for reporting, planning, analysis and simulation, in February 2018.

Editor's Details

Mark de Wolf

Last updated on: 04/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.